Stem cell project to cure AMD underway

Article

Researchers from University College London (UCL), Moorfields Eye Hospital and the University of Sheffield, UK are launching a pioneering project that plans to use stem cells to cure blindness resulting from age-related macular degeneration.

Researchers from University College London (UCL), Moorfields Eye Hospital and the University of Sheffield, UK are launching a pioneering project that plans to use stem cells to cure blindness resulting from age-related macular degeneration (AMD).

The procedure will generate replacement retinal pigment epithelial (RPE) cells from stem cells in the laboratory. Surgeons will then inject a small patch of new cells, measuring 4 x 6 mm, back into the eye.

An anonymous US donor, frustrated by the US curb on stem cell research, has made the project possible by donating £4 million. The researchers hope that, if successful, the operation could become as routine as cataract surgery.

It is hoped that the first test patients will receive the treatment in just five years time.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.